Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Rheumatoid Arthritis

Free Subscription Articles published in Lancet Retrieve available abstracts of 7 articles: HTML format

Single Articles

September 2022
1. BOWMAN SJ, Dorner T, Mariette X, Luo WL, et al
   Ianalumab in Sjogren's syndrome: what can we learn from lupus trials? - Authors' reply.
   Lancet. 2022;400:808-809.
   PubMed    
   
   
   
2. DYBALL S, Parker B, Bruce IN
   Ianalumab in Sjogren's syndrome: what can we learn from lupus trials?
   Lancet. 2022;400:807-808.
   PubMed    
   
   
   July 2022
3. KRIJBOLDER DI, Verstappen M, van Dijk BT, Dakkak YJ, et al
   Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial
   Lancet. 2022;400:283-294.
   PubMed     Abstract available
   
   
   
4. RECH J, Schett G
   Towards preventive treatment of rheumatoid arthritis.
   Lancet. 2022;400:253-255.
   PubMed    
   
   
   January 2022
5. SARAUX A, Devauchelle-Pensec V
   Primary Sjogren's syndrome: new beginning for evidence-based trials.
   Lancet. 2022;399:121-122.
   PubMed    
   
   
   
6. BOWMAN SJ, Fox R, Dorner T, Mariette X, et al
   Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjogren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
   Lancet. 2022;399:161-171.
   PubMed     Abstract available
   
   
   August 2021
7. MCLORNAN DP, Pope JE, Gotlib J, Harrison CN, et al
   Current and future status of JAK inhibitors.
   Lancet. 2021;398:803-816.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: